(yng)} |
iɳ̹ |
a(chn)أ |
h |
(bio)(zhn) |
99% |
Ҏ(gu) |
99% |
r |
10 |
Jλ |
|
a(chn)ƷB |
iɳ̹
ӢQValsartan
CAS ̖137862-53-4
a(chn)Ʒf
Qiɳ̹
ӢQ Valsartan
hZƴXieshatan
SB3Vitamin B3
W(xu)Q(S)-N--N-[2-(1H-ĵ-5-)[1,1-(lin)]-4-]-iᡡ
ʽ C24H29N5O3435.53
CAS 137862-53-4
|(zh)ƷɫɫY(ji)ԷĩooζҴͪИOܽڼ״ȷܣˮЎܡc197200
c;ˎiɳ̹Ѫܾoآ(Ang)wxԵAngcAT1wĽY(ji)ϣخAT1wôAT2s20,000ĶѪտsȩͪጷţa(chn)
bcAأ Ҏ(gu)b20 kg4Ͱ1kgXbƷڼͰ(ni)(ni)rţƤrϴͰwFȦUܹ]档
iɳ̹Valsartan
ӢĻW(xu)3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoic acid
ĻW(xu) N-(1-)-N-[4-[2-(1H-ĵ-5-)]S]-L-i
CAS NO137862-53-4
Y(ji)(gu)ʽ:
iɳ̹Ԕ(x)Ϣ
[1]
ʽC24H29N5O3 435.52
ˎf
eiɳ̹,
Valsartn,DIOVAN
Rԇδl(f)F(xin)ˎcˎgRxã涡Aף૱ᣩظ堖ມȵƽбڴ(iovan)xc(x)ɫP450øϵy(tng)T(do)Ƅͨl(f)RxáMiɳ̹(Valsartan)cѪ{Y(ji)ʸw⌍ˎcѪ{Y(ji)ʸߵˎpȷף૱ᣩA֮goѪ{Y(ji)Ϸác݃(ni)Ƅ⛵}ƷÕrʹѪͬrã(yng)עO(jin)y
÷
(Diovan)]80mgÿһ,cNgԄeoP(gun)Ѫͨڷˎ2܃(ni)F(xin),4ܕr_(d)ЧѪƲMIJˣÿ160mgIܲȫođԴԼđ֭eιܲȫߟo{(dio)(ji)(Diovan)cѪˎ
ҹ˾Ҫa(chn)ϵ 仯 - 4- 4- 4-u 3- 2- -ȩ ȩ ȩҿsȩ ᱽ 4- 4-uS ֬ S ϩ ᱽ ᮐ ᮐ ᮐ @ 3,4,5-
ԭˎ
1.Ѫϵ 1.б 2. R 3. ͪ 4. Ǹ 5. 6. 7͡ 8. iɳ̹ 9. ؐɳ̹ 10 ɳ̹
2.ϵУ1.俵 2. (lin)S 3. 4.ù
3.Zͪˎ1. }ɳ 2. }ɳ 3. h(hun)ɳ 4. }h(hun)ɳ 5. h(hun)ɳ 6.Zɳ 7. }Zɳ 8.Zɳ 9. Zɳ 10. Zɳ 11. }Zɳ 12. Zɳc
4. (zhn)ʹ1. ˽ 2. 3. 4. 5c
6.pȷc 7. pȷ 8. pȷҰ}
5.x1. а 2. }ᰱ 3.ǰc 4. ǰc 5. 6. ؿ 7. ˮܵؿ 8. 9.S 10.S 11.Rù@ 12.u 13. Ῠ
gӭVÑԃ 027-88082817/13437191636
|
l(f)rg |
2011/1/14 11:08:00 |
|